Mednet Logo
HomeRadiation OncologyQuestion

Is there evidence supporting the role of SBRT in the management of oligometastatic stage IV NSCLC?

2
2 Answers
Mednet Member
Mednet Member
Radiation Oncology · University of Texas at Tyler

Yes. I would look at a great trial from Wake Forest, looking at consolidative radiotherapy after 3-6 cycles of platinum-based chemotherapy, followed by observation, so chemotherapy, then radiotherapy, then observation (no maintenance chemotherapy). The trial occurred from 2010 to 2015. This single-a...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Texas at Tyler

To define a population undergoing active treatment with effective systemic agents that might benefit from LCT requires a nuanced approach, given that tumor response may operate in a time-dependent manner depending on the systemic agent used. The definition of oligometastasis: site, volume, and numbe...

Register or Sign In to see full answer